ASF1B and hepatocellular carcinoma: Interestingly, prognostic analysis showed that HCC patients with high ASF1B expression levels had worse disease-free survival (DFS) and higher HR-relapse in the decreased B cells, decreased CD8+ T cells, decreased neutrophils, and enriched CD4+ T cells subgroups.